A modern approach to the treatment of plaque psoriasis

Daniela Ledić Drvar1, Tomislav Vlahinić2, Željan Maleš3

  • 1Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, HR-10000Zagreb, Croatia.

Insights

Psoriasis is a chronic inflammatory skin condition affecting 1.6% of the Croatian population. Its development involves genetics, immune issues, and environmental factors, with targeted therapies advancing personalized medicine.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Psoriasis is a prevalent chronic inflammatory skin disease affecting 0.5-3% globally and 1.6% in Croatia.
  • Disease prevalence shows a bimodal distribution with peaks in young adulthood (20-30) and later adulthood (50-60).
  • Multifactorial etiopathogenesis involves genetic predisposition, immune dysregulation, environmental triggers, and compromised skin barrier function.

Purpose of the Study:

  • To review the epidemiology, etiopathogenesis, clinical variants, and treatment strategies for psoriasis.
  • To highlight the role of key signaling pathways such as TNF-α, IL-23, and IL-17.
  • To discuss the evolution towards personalized medicine in psoriasis management.

Main Methods:

  • Literature review of epidemiological data, etiological factors, and therapeutic approaches.
  • Analysis of key molecular pathways implicated in psoriasis pathogenesis.
  • Examination of current and emerging treatment modalities.

Main Results:

  • Psoriasis affects diverse age groups with distinct epidemiological patterns.
  • Genetic and immunological factors, alongside environmental influences, are central to disease development.
  • Targeted therapies are crucial for moderate-to-severe cases unresponsive to conventional treatments.

Conclusions:

  • Understanding psoriasis's complex etiology is key to effective management.
  • Advancements in immunogenetics are driving the development of personalized treatment strategies.
  • The future of psoriasis care lies in tailored, targeted therapeutic interventions.

Related Concept Videos

Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
551
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
225
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
420
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
287
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
426
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
211